Improvements seen in cognition, cholesterol, blood sugar, and C-reactive protein

Association between schizophrenia and cardiovascular disease events more pronounced in women than men

However, neurocognitive declines are seen in others, which is tied to other poor outcomes

Significant improvements seen at eight months for positive symptoms and hallucinations, delusions

Reduction in 30-day readmission rate seen for schizophrenia or schizoaffective disorder with long-acting versus oral antipsychotics

In a recent study, severe QT prolongation occurred in 13.0 percent of quetiapine and 14.2 percent of haloperidol users

Researchers found that few individuals with psychotic disorders have participated in vocational training

74.9 additional visits for schizophrenia spectrum disorders seen at three months after initial phase of COVID-19 pandemic

Twenty transcranial magnetic stimulation treatments over four weeks result in improvement in event-based prospective memory

Findings show dose-response relationship, with highest risk for autism, intellectual disability, tic disorder, depression, biopolar disorder